The Leser-Trélat sign is a rare sign of some malignant tumors and is characterized by the sudden appearance of seborrheic keratosis in association with an underlying malignancy. We describe a 60-year-old Saudi man with mycosis fungoides (MF) who developed numerous, rapidly growing, seborrheic keratoses on his face and back. To the best of our knowledge, this is the first reported case of MF with the Leser-Trélat sign from Saudi Arabia.

The sign of Leser-Trélat (LT) is characterized by the abrupt appearance of multiple seborrheic keratoses, sometimes associated with pruritus in association with an underlying malignancy [1, 2]. It has been reported as a paraneoplastic disease in the setting of various types of malignancies, most commonly adenocarcinoma of the stomach [3, 4]. However, a few cases of mycosis fungoides (MF) with LT sign have been reported [5-9]. To the best of our knowledge, no cases of LT sign have been reported among the Saudi population.

A 60-year-old male presented to the Dermatology Clinic at the King Khalid Hospital on 2007 with a 3-year history of itchy, confluent, erythematous, mildly scaling macules and patches on his trunk and extremities. The body surface involvement was around 30%. The physical examination was otherwise unremarkable. Histopathological evaluation revealed features consistent with MF. Investigations (complete blood cell count [CBC], liver function [LFT], urea and electrolyte [U/E], lactate dehydrogenase [LDH], peripheral blood flow cytometry tests and CT of chest, abdomen, and pelvis) were all normal.

A diagnosis of patch-stage MF (stage IB; TII, N0, M0) was made. The patient was started on treatment with narrowband ultraviolet B 3 times weekly for 9 months with complete clearance, and skin biopsy showed no evidence of MF. The follow-up showed a lasting remission of the disease over the next 5 years; then he missed his follow-up for 3 years. In March 2017, the patient presented to our clinic with progressive itchy erythematous patches on the trunk of 9 months’ duration, and he had noted the sudden appearance of multiple black-colored lesions over his face and trunk.

On examination, there were multiple erythematous scaly plaques on his abdomen and thighs, the body surface involvement was around 8%, and there were numerous seborrheic keratoses on his face, upper limbs, and trunk (Fig. 1, 2). There was no lymphadenopathy or organomegaly.

Fig. 1.

Clinical picture of the eruption of the seborrheic keratosis over face.

Fig. 1.

Clinical picture of the eruption of the seborrheic keratosis over face.

Close modal
Fig. 2.

Clinical picture of the eruption of the seborrheic keratosis over back and multiple lesions of MF.

Fig. 2.

Clinical picture of the eruption of the seborrheic keratosis over back and multiple lesions of MF.

Close modal

A biopsy specimen taken from an erythematous plaque on his left lower back showed focal parakeratosis and mild epidermal hyperplasia. There was superficial lymphocytic infiltrate in the superficial dermis with epidermatotropism of few atypical looking cells. By immunohistochemistry stains, these cells are positive for CD3 and CD4 with a marked decrease in CD7 and CD8. Another biopsy taken from his upper back showed acanthosis, pigmented keratinocytes, and pseudohorn cysts consistent with seborrheic keratosis (Fig. 3, 4).

Fig. 3.

Upper back lesion reveals acanthosis, pigmented keratinocytes, and pseudohorn cysts consistent with seborrheic keratosis. H/E stain. ×100.

Fig. 3.

Upper back lesion reveals acanthosis, pigmented keratinocytes, and pseudohorn cysts consistent with seborrheic keratosis. H/E stain. ×100.

Close modal
Fig. 4.

Biopsy from right lower back exhibits atypical lymphocytes in epidermis with papillary dermal fibrosis. H/E stain. ×400.

Fig. 4.

Biopsy from right lower back exhibits atypical lymphocytes in epidermis with papillary dermal fibrosis. H/E stain. ×400.

Close modal

A comprehensive investigation panel, including CBC with differential, LFT, U/E, and LDH, was normal. Flow cytometry of the peripheral blood was normal, and the CD4/CD8 ratio was normal. CT of chest, abdomen, and pelvis was done and showed no lymphadenopathy or organomegaly.

The sign of LT is characterized by a sudden eruption of many new seborrheic keratoses or a rapid increase in their size over a short time (weeks or months), often associated with pruritus and primarily affecting the upper trunk and the dorsum of hands, followed by extremities, face, abdomen, neck, and axilla [10]. As suggested by Heaphy et al. [11] the “syndrome of Leser-Trélat” is defined as a paraneoplastic syndrome in patients with the “sign of Leser-Trélat,” in whom an occult malignancy is identified after the appearance of the sign. However, detecting the sign upon history and physical examination alone with or without the association with occult malignancy can be referred to as the “sign of Leser-Trélat.”

LT is predominantly associated with solid organ carcinomas and rarely occurs in association with hematopoietic malignancies, especially cutaneous T-cell lymphoma; only 10 cases of the LT sign have previously been reported in the setting of MF [8, 9].

In this report, the patient initially presented with itchy, confluent, erythematous, mildly scaling macules and patches on his trunk and extremities, representing the patch-stage MF (stage IB; TII, N0, M0). This was followed by the multiple black-colored lesions over his face and trunk 10 years after confirming his diagnosis of MF. This was different from a case reported from Japan [7], where the patient developed brownish papules on the front of her neck and chest only a few weeks before the development of the generalized erythematous eruption. In another case reported by Narala et al. [8], the patient noted several brown skin lesions concurrent with a red, scaly rash over the entire body, which could be related to the fact that the patient did not comply with his appointments, leading to a late diagnosis. Also, the differences in the timing of LT sign presentation in relation to MF lesions indicate that it is not associated with the aggressiveness or stage of MF.

Miyako et al. [7] suggested a specific LT sign pattern that could be linked to an MF-associated LT sign. They noted that LT sign did not develop in a typical way; seborrheic keratoses appeared only on the neck and chest, and they did not further increase in size. In our patient, LT sign had developed over his face and trunk, questioning the suggested pattern of MF-associated LT sign.

Seborrheic keratoses are common findings in elderly patients. Therefore, patients with a sign of LT should undergo a diagnostic screening program for malignant disease. Moreover, these lesions may coexist with the diagnosis of different types of cancers, or follow or precede it by months or years.

Patient informed consent was signed by the patient.

The authors report no financial and personal interests and have no conflicts of interest.

1.
Leser
E
.
Ueber ein die Krebskrankheit beim Menschen haufig begleitendes, noch wenig gekanntes Symptom
.
Munch Med Wochenschr
.
1901
;
51
:
2035
6
.0027-2973
2.
Pipkin
CA
,
Lio
PA
.
Cutaneous manifestations of internal malignancies: an overview
.
[vii.]
.
Dermatol Clin
.
2008
Jan
;
26
(
1
):
1
15
.
[PubMed]
0733-8635
3.
Lindelöf
B
,
Sigurgeirsson
B
,
Melander
S
.
Seborrheic keratoses and cancer
.
J Am Acad Dermatol
.
1992
Jun
;
26
(
6
):
947
50
.
[PubMed]
0190-9622
4.
Schwengle
LE
,
Rampen
FH
,
Wobbes
T
.
Seborrhoeic keratoses and internal malignancies. A case control study
.
Clin Exp Dermatol
.
1988
May
;
13
(
3
):
177
9
.
[PubMed]
0307-6938
5.
Cohen
JH
,
Lessin
SR
,
Vowels
BR
,
Benoit
B
,
Witmer
WK
,
Rook
AH
.
The sign of Leser-Trélat in association with Sézary syndrome: simultaneous disappearance of seborrheic keratoses and malignant T-cell clone during combined therapy with photopheresis and interferon alfa
.
Arch Dermatol
.
1993
Sep
;
129
(
9
):
1213
5
.
[PubMed]
0003-987X
6.
McCrary
ML
,
Davis
LS
.
Sign of Leser-Trélat and mycosis fungoides
.
J Am Acad Dermatol
.
1998
Apr
;
38
(
4
):
644
.
[PubMed]
0190-9622
7.
Miyako
F
,
Dekio
S
,
Tamura
H
,
Yamada
Y
,
Miyata
N
,
Jidoi
J
, et al
Mycosis fungoides with Leser-Trélat sign: the first report of a patient from Japan
.
J Dermatol
.
1994
Mar
;
21
(
3
):
189
93
.
[PubMed]
0385-2407
8.
Narala
S
,
Cohen
PR
.
Cutaneous T-cell lymphoma-associated Leser-Trélat sign: report and world literature review
.
Dermatol Online J
.
2017
Jan
;
23
(
1
):
23
.
[PubMed]
1087-2108
9.
Rowe
B
,
Shevchenko
A
,
Yosipovitch
G
.
Leser-Trélat Sign in Tumor-Stage Mycosis Fungoides
.
Dermatol Online J
.
2016
Apr
;
22
(
4
):
22
.
[PubMed]
1087-2108
10.
Silva
JA
,
Mesquita
KC
,
Igreja
AC
,
Lucas
IC
,
Freitas
AF
,
Oliveira
SM
, et al
Paraneoplastic cutaneous manifestations: concepts and updates
.
An Bras Dermatol
.
2013
Jan-Feb
;
88
(
1
):
9
22
.
[PubMed]
0365-0596
11.
Heaphy
MR
 Jr
,
Millns
JL
,
Schroeter
AL
.
The sign of Leser-Trélat in a case of adenocarcinoma of the lung
.
J Am Acad Dermatol
.
2000
Aug
;
43
(
2 Pt 2
):
386
90
.
[PubMed]
0190-9622
Open Access License / Drug Dosage / Disclaimer
This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.